Global Anti-angiogenic Agent Sales Market Report 2016

December 2016 | 101 pages | ID: G4D45C809A9EN
QYResearch

Abstracts

Notes:

Sales, means the sales volume of Anti-angiogenic Agent

Revenue, means the sales value of Anti-angiogenic Agent

This report studies sales (consumption) of Anti-angiogenic Agent in Global market, especially in United States, China, Europe, Japan, focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these regions, covering

• Pfizer, Inc. (US)
• Eli Lilly and Company (USA)
• Bayer HealthCare Pharmaceuticals, Inc. (USA)
• Abbott Laboratories (USA)
• AstraZeneca Plc. (UK)
• Meditrina Pharmaceuticals, Inc. (US)
• Neurocrine Biosciences, Inc. (US)
• AEterna Zentaris, Inc. (Canada)

Market Segment by Regions, this report splits Global into several key Regions, with sales (consumption), revenue, market share and growth rate of Anti-angiogenic Agent in these regions, from 2011 to 2021 (forecast), like

• United States
• China
• Europe
• Japan

Split by product Types, with sales, revenue, price and gross margin, market share and growth rate of each type, can be divided into

• Type I
• Type II
• Type III

Split by applications, this report focuses on sales, market share and growth rate of Anti-angiogenic Agent in each application, can be divided into

• Application 1
• Application 2
• Application 3

Contents

Global Anti-angiogenic Agent Sales Market Report 2016

1 ANTI-ANGIOGENIC AGENT OVERVIEW

1.1 Product Overview and Scope of Anti-angiogenic Agent
1.2 Classification of Anti-angiogenic Agent
  1.2.1 Type I
  1.2.2 Type II
  1.2.3 Type III
1.3 Application of Anti-angiogenic Agent
  1.3.1 Application
  1.3.2 Application
  1.3.3 Application
1.4 Anti-angiogenic Agent Market by Regions
  1.4.1 United States Status and Prospect (2011-2021)
  1.4.2 China Status and Prospect (2011-2021)
  1.4.3 Europe Status and Prospect (2011-2021)
  1.4.4 Japan Status and Prospect (2011-2021)
1.5 Global Market Size (Value and Volume) of Anti-angiogenic Agent (2011-2021)
  1.5.1 Global Anti-angiogenic Agent Sales and Growth Rate (2011-2021)
  1.5.2 Global Anti-angiogenic Agent Revenue and Growth Rate (2011-2021)

2 GLOBAL ANTI-ANGIOGENIC AGENT COMPETITION BY MANUFACTURERS, TYPE AND APPLICATION

2.1 Global Anti-angiogenic Agent Market Competition by Manufacturers
  2.1.1 Global Anti-angiogenic Agent Sales and Market Share of Key Manufacturers (2011-2016)
  2.1.2 Global Anti-angiogenic Agent Revenue and Share by Manufacturers (2011-2016)
2.2 Global Anti-angiogenic Agent (Volume and Value) by Type
  2.2.1 Global Anti-angiogenic Agent Sales and Market Share by Type (2011-2016)
  2.2.2 Global Anti-angiogenic Agent Revenue and Market Share by Type (2011-2016)
2.3 Global Anti-angiogenic Agent (Volume and Value) by Regions
  2.3.1 Global Anti-angiogenic Agent Sales and Market Share by Regions (2011-2016)
  2.3.2 Global Anti-angiogenic Agent Revenue and Market Share by Regions (2011-2016)
2.4 Global Anti-angiogenic Agent (Volume) by Application

3 UNITED STATES ANTI-ANGIOGENIC AGENT (VOLUME, VALUE AND SALES PRICE)

3.1 United States Anti-angiogenic Agent Sales and Value (2011-2016)
  3.1.1 United States Anti-angiogenic Agent Sales and Growth Rate (2011-2016)
  3.1.2 United States Anti-angiogenic Agent Revenue and Growth Rate (2011-2016)
  3.1.3 United States Anti-angiogenic Agent Sales Price Trend (2011-2016)
3.2 United States Anti-angiogenic Agent Sales and Market Share by Manufacturers
3.3 United States Anti-angiogenic Agent Sales and Market Share by Type
3.4 United States Anti-angiogenic Agent Sales and Market Share by Application

4 CHINA ANTI-ANGIOGENIC AGENT (VOLUME, VALUE AND SALES PRICE)

4.1 China Anti-angiogenic Agent Sales and Value (2011-2016)
  4.1.1 China Anti-angiogenic Agent Sales and Growth Rate (2011-2016)
  4.1.2 China Anti-angiogenic Agent Revenue and Growth Rate (2011-2016)
  4.1.3 China Anti-angiogenic Agent Sales Price Trend (2011-2016)
4.2 China Anti-angiogenic Agent Sales and Market Share by Manufacturers
4.3 China Anti-angiogenic Agent Sales and Market Share by Type
4.4 China Anti-angiogenic Agent Sales and Market Share by Application

5 EUROPE ANTI-ANGIOGENIC AGENT (VOLUME, VALUE AND SALES PRICE)

5.1 Europe Anti-angiogenic Agent Sales and Value (2011-2016)
  5.1.1 Europe Anti-angiogenic Agent Sales and Growth Rate (2011-2016)
  5.1.2 Europe Anti-angiogenic Agent Revenue and Growth Rate (2011-2016)
  5.1.3 Europe Anti-angiogenic Agent Sales Price Trend (2011-2016)
5.2 Europe Anti-angiogenic Agent Sales and Market Share by Manufacturers
5.3 Europe Anti-angiogenic Agent Sales and Market Share by Type
5.4 Europe Anti-angiogenic Agent Sales and Market Share by Application

6 JAPAN ANTI-ANGIOGENIC AGENT (VOLUME, VALUE AND SALES PRICE)

6.1 Japan Anti-angiogenic Agent Sales and Value (2011-2016)
  6.1.1 Japan Anti-angiogenic Agent Sales and Growth Rate (2011-2016)
  6.1.2 Japan Anti-angiogenic Agent Revenue and Growth Rate (2011-2016)
  6.1.3 Japan Anti-angiogenic Agent Sales Price Trend (2011-2016)
6.2 Japan Anti-angiogenic Agent Sales and Market Share by Manufacturers
6.3 Japan Anti-angiogenic Agent Sales and Market Share by Type
6.4 Japan Anti-angiogenic Agent Sales and Market Share by Application

7 GLOBAL ANTI-ANGIOGENIC AGENT MANUFACTURERS ANALYSIS

7.1 Pfizer, Inc. (US)
  7.1.1 Company Basic Information, Manufacturing Base and Competitors
  7.1.2 Anti-angiogenic Agent Product Type, Application and Specification
    7.1.2.1 Type I
    7.1.2.2 Type II
  7.1.3 Pfizer, Inc. (US) Anti-angiogenic Agent Sales, Revenue, Price and Gross Margin (2011-2016)
  7.1.4 Main Business/Business Overview
7.2 Eli Lilly and Company (USA)
  7.2.1 Company Basic Information, Manufacturing Base and Competitors
  7.2.2 101 Product Type, Application and Specification
    7.2.2.1 Type I
    7.2.2.2 Type II
  7.2.3 Eli Lilly and Company (USA) Anti-angiogenic Agent Sales, Revenue, Price and Gross Margin (2011-2016)
  7.2.4 Main Business/Business Overview
7.3 Bayer HealthCare Pharmaceuticals, Inc. (USA)
  7.3.1 Company Basic Information, Manufacturing Base and Competitors
  7.3.2 128 Product Type, Application and Specification
    7.3.2.1 Type I
    7.3.2.2 Type II
  7.3.3 Bayer HealthCare Pharmaceuticals, Inc. (USA) Anti-angiogenic Agent Sales, Revenue, Price and Gross Margin (2011-2016)
  7.3.4 Main Business/Business Overview
7.4 Abbott Laboratories (USA)
  7.4.1 Company Basic Information, Manufacturing Base and Competitors
  7.4.2 Dec Product Type, Application and Specification
    7.4.2.1 Type I
    7.4.2.2 Type II
  7.4.3 Abbott Laboratories (USA) Anti-angiogenic Agent Sales, Revenue, Price and Gross Margin (2011-2016)
  7.4.4 Main Business/Business Overview
7.5 AstraZeneca Plc. (UK)
  7.5.1 Company Basic Information, Manufacturing Base and Competitors
  7.5.2 Product Type, Application and Specification
    7.5.2.1 Type I
    7.5.2.2 Type II
  7.5.3 AstraZeneca Plc. (UK) Anti-angiogenic Agent Sales, Revenue, Price and Gross Margin (2011-2016)
  7.5.4 Main Business/Business Overview
7.6 Meditrina Pharmaceuticals, Inc. (US)
  7.6.1 Company Basic Information, Manufacturing Base and Competitors
  7.6.2 Million USD Product Type, Application and Specification
    7.6.2.1 Type I
    7.6.2.2 Type II
  7.6.3 Meditrina Pharmaceuticals, Inc. (US) Anti-angiogenic Agent Sales, Revenue, Price and Gross Margin (2011-2016)
  7.6.4 Main Business/Business Overview
7.7 Neurocrine Biosciences, Inc. (US)
  7.7.1 Company Basic Information, Manufacturing Base and Competitors
  7.7.2 Pharma & Healthcare Product Type, Application and Specification
    7.7.2.1 Type I
    7.7.2.2 Type II
  7.7.3 Neurocrine Biosciences, Inc. (US) Anti-angiogenic Agent Sales, Revenue, Price and Gross Margin (2011-2016)
  7.7.4 Main Business/Business Overview
7.8 AEterna Zentaris, Inc. (Canada)
  7.8.1 Company Basic Information, Manufacturing Base and Competitors
  7.8.2 Product Type, Application and Specification
    7.8.2.1 Type I
    7.8.2.2 Type II
  7.8.3 AEterna Zentaris, Inc. (Canada) Anti-angiogenic Agent Sales, Revenue, Price and Gross Margin (2011-2016)
  7.8.4 Main Business/Business Overview

8 ANTI-ANGIOGENIC AGENT MAUFACTURING COST ANALYSIS

8.1 Anti-angiogenic Agent Key Raw Materials Analysis
  8.1.1 Key Raw Materials
  8.1.2 Price Trend of Key Raw Materials
  8.1.3 Key Suppliers of Raw Materials
  8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
  8.2.1 Raw Materials
  8.2.2 Labor Cost
  8.2.3 Manufacturing Process Analysis of Anti-angiogenic Agent

9 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

9.1 Anti-angiogenic Agent Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of Anti-angiogenic Agent Major Manufacturers in 2015
9.4 Downstream Buyers

10 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

10.1 Marketing Channel
  10.1.1 Direct Marketing
  10.1.2 Indirect Marketing
  10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
  10.2.1 Pricing Strategy
  10.2.2 Brand Strategy
  10.2.3 Target Client
10.3 Distributors/Traders List

11 MARKET EFFECT FACTORS ANALYSIS

11.1 Technology Progress/Risk
  11.1.1 Substitutes Threat
  11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change

12 GLOBAL ANTI-ANGIOGENIC AGENT MARKET FORECAST (2016-2021)

12.1 Global Anti-angiogenic Agent Sales, Revenue Forecast (2016-2021)
12.2 Global Anti-angiogenic Agent Sales Forecast by Regions (2016-2021)
12.3 Global Anti-angiogenic Agent Sales Forecast by Type (2016-2021)
12.4 Global Anti-angiogenic Agent Sales Forecast by Application (2016-2021)

13 APPENDIX

Disclosure Section
Research Methodology
Data Source
China Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Anti-angiogenic Agent
Table Classification of Anti-angiogenic Agent
Figure Global Sales Market Share of Anti-angiogenic Agent by Type in 2015
Figure Type I Picture
Figure Type II Picture
Table Applications of Anti-angiogenic Agent
Figure Global Sales Market Share of Anti-angiogenic Agent by Application in 2015
Figure Application 1 Examples
Figure Application 2 Examples
Figure United States Anti-angiogenic Agent Revenue and Growth Rate (2011-2021)
Figure China Anti-angiogenic Agent Revenue and Growth Rate (2011-2021)
Figure Europe Anti-angiogenic Agent Revenue and Growth Rate (2011-2021)
Figure Japan Anti-angiogenic Agent Revenue and Growth Rate (2011-2021)
Figure Global Anti-angiogenic Agent Sales and Growth Rate (2011-2021)
Figure Global Anti-angiogenic Agent Revenue and Growth Rate (2011-2021)
Table Global Anti-angiogenic Agent Sales of Key Manufacturers (2011-2016)
Table Global Anti-angiogenic Agent Sales Share by Manufacturers (2011-2016)
Figure 2015 Anti-angiogenic Agent Sales Share by Manufacturers
Figure 2016 Anti-angiogenic Agent Sales Share by Manufacturers
Table Global Anti-angiogenic Agent Revenue by Manufacturers (2011-2016)
Table Global Anti-angiogenic Agent Revenue Share by Manufacturers (2011-2016)
Table 2015 Global Anti-angiogenic Agent Revenue Share by Manufacturers
Table 2016 Global Anti-angiogenic Agent Revenue Share by Manufacturers
Table Global Anti-angiogenic Agent Sales and Market Share by Type (2011-2016)
Table Global Anti-angiogenic Agent Sales Share by Type (2011-2016)
Figure Sales Market Share of Anti-angiogenic Agent by Type (2011-2016)
Figure Global Anti-angiogenic Agent Sales Growth Rate by Type (2011-2016)
Table Global Anti-angiogenic Agent Revenue and Market Share by Type (2011-2016)
Table Global Anti-angiogenic Agent Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Anti-angiogenic Agent by Type (2011-2016)
Figure Global Anti-angiogenic Agent Revenue Growth Rate by Type (2011-2016)
Table Global Anti-angiogenic Agent Sales and Market Share by Regions (2011-2016)
Table Global Anti-angiogenic Agent Sales Share by Regions (2011-2016)
Figure Sales Market Share of Anti-angiogenic Agent by Regions (2011-2016)
Figure Global Anti-angiogenic Agent Sales Growth Rate by Regions (2011-2016)
Table Global Anti-angiogenic Agent Revenue and Market Share by Regions (2011-2016)
Table Global Anti-angiogenic Agent Revenue Share by Regions (2011-2016)
Figure Revenue Market Share of Anti-angiogenic Agent by Regions (2011-2016)
Figure Global Anti-angiogenic Agent Revenue Growth Rate by Regions (2011-2016)
Table Global Anti-angiogenic Agent Sales and Market Share by Application (2011-2016)
Table Global Anti-angiogenic Agent Sales Share by Application (2011-2016)
Figure Sales Market Share of Anti-angiogenic Agent by Application (2011-2016)
Figure Global Anti-angiogenic Agent Sales Growth Rate by Application (2011-2016)
Figure United States Anti-angiogenic Agent Sales and Growth Rate (2011-2016)
Figure United States Anti-angiogenic Agent Revenue and Growth Rate (2011-2016)
Figure United States Anti-angiogenic Agent Sales Price Trend (2011-2016)
Table United States Anti-angiogenic Agent Sales by Manufacturers (2011-2016)
Table United States Anti-angiogenic Agent Market Share by Manufacturers (2011-2016)
Table United States Anti-angiogenic Agent Sales by Type (2011-2016)
Table United States Anti-angiogenic Agent Market Share by Type (2011-2016)
Table United States Anti-angiogenic Agent Sales by Application (2011-2016)
Table United States Anti-angiogenic Agent Market Share by Application (2011-2016)
Figure China Anti-angiogenic Agent Sales and Growth Rate (2011-2016)
Figure China Anti-angiogenic Agent Revenue and Growth Rate (2011-2016)
Figure China Anti-angiogenic Agent Sales Price Trend (2011-2016)
Table China Anti-angiogenic Agent Sales by Manufacturers (2011-2016)
Table China Anti-angiogenic Agent Market Share by Manufacturers (2011-2016)
Table China Anti-angiogenic Agent Sales by Type (2011-2016)
Table China Anti-angiogenic Agent Market Share by Type (2011-2016)
Table China Anti-angiogenic Agent Sales by Application (2011-2016)
Table China Anti-angiogenic Agent Market Share by Application (2011-2016)
Figure Europe Anti-angiogenic Agent Sales and Growth Rate (2011-2016)
Figure Europe Anti-angiogenic Agent Revenue and Growth Rate (2011-2016)
Figure Europe Anti-angiogenic Agent Sales Price Trend (2011-2016)
Table Europe Anti-angiogenic Agent Sales by Manufacturers (2011-2016)
Table Europe Anti-angiogenic Agent Market Share by Manufacturers (2011-2016)
Table Europe Anti-angiogenic Agent Sales by Type (2011-2016)
Table Europe Anti-angiogenic Agent Market Share by Type (2011-2016)
Table Europe Anti-angiogenic Agent Sales by Application (2011-2016)
Table Europe Anti-angiogenic Agent Market Share by Application (2011-2016)
Figure Japan Anti-angiogenic Agent Sales and Growth Rate (2011-2016)
Figure Japan Anti-angiogenic Agent Revenue and Growth Rate (2011-2016)
Figure Japan Anti-angiogenic Agent Sales Price Trend (2011-2016)
Table Japan Anti-angiogenic Agent Sales by Manufacturers (2011-2016)
Table Japan Anti-angiogenic Agent Market Share by Manufacturers (2011-2016)
Table Japan Anti-angiogenic Agent Sales by Type (2011-2016)
Table Japan Anti-angiogenic Agent Market Share by Type (2011-2016)
Table Japan Anti-angiogenic Agent Sales by Application (2011-2016)
Table Japan Anti-angiogenic Agent Market Share by Application (2011-2016)
Table Pfizer, Inc. (US) Basic Information List
Table Pfizer, Inc. (US) Anti-angiogenic Agent Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Pfizer, Inc. (US) Anti-angiogenic Agent Global Market Share (2011-2016)
Table Eli Lilly and Company (USA) Basic Information List
Table Eli Lilly and Company (USA) Anti-angiogenic Agent Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Eli Lilly and Company (USA) Anti-angiogenic Agent Global Market Share (2011-2016)
Table Bayer HealthCare Pharmaceuticals, Inc. (USA) Basic Information List
Table Bayer HealthCare Pharmaceuticals, Inc. (USA) Anti-angiogenic Agent Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Bayer HealthCare Pharmaceuticals, Inc. (USA) Anti-angiogenic Agent Global Market Share (2011-2016)
Table Abbott Laboratories (USA) Basic Information List
Table Abbott Laboratories (USA) Anti-angiogenic Agent Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Abbott Laboratories (USA) Anti-angiogenic Agent Global Market Share (2011-2016)
Table AstraZeneca Plc. (UK) Basic Information List
Table AstraZeneca Plc. (UK) Anti-angiogenic Agent Sales, Revenue, Price and Gross Margin (2011-2016)
Figure AstraZeneca Plc. (UK) Anti-angiogenic Agent Global Market Share (2011-2016)
Table Meditrina Pharmaceuticals, Inc. (US) Basic Information List
Table Meditrina Pharmaceuticals, Inc. (US) Anti-angiogenic Agent Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Meditrina Pharmaceuticals, Inc. (US) Anti-angiogenic Agent Global Market Share (2011-2016)
Table Neurocrine Biosciences, Inc. (US) Basic Information List
Table Neurocrine Biosciences, Inc. (US) Anti-angiogenic Agent Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Neurocrine Biosciences, Inc. (US) Anti-angiogenic Agent Global Market Share (2011-2016)
Table AEterna Zentaris, Inc. (Canada) Basic Information List
Table AEterna Zentaris, Inc. (Canada) Anti-angiogenic Agent Sales, Revenue, Price and Gross Margin (2011-2016)
Figure AEterna Zentaris, Inc. (Canada) Anti-angiogenic Agent Global Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Anti-angiogenic Agent
Figure Manufacturing Process Analysis of Anti-angiogenic Agent
Figure Anti-angiogenic Agent Industrial Chain Analysis
Table Raw Materials Sources of Anti-angiogenic Agent Major Manufacturers in 2015
Table Major Buyers of Anti-angiogenic Agent
Table Distributors/Traders List
Figure Global Anti-angiogenic Agent Sales and Growth Rate Forecast (2016-2021)
Figure Global Anti-angiogenic Agent Revenue and Growth Rate Forecast (2016-2021)
Table Global Anti-angiogenic Agent Sales Forecast by Regions (2016-2021)
Table Global Anti-angiogenic Agent Sales Forecast by Type (2016-2021)
Table Global Anti-angiogenic Agent Sales Forecast by Application (2016-2021)